Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,204.40
(
0.00%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
98.58
(
1.92%
)
Bitcoin
78,204.30
(
-0.04%
)
News Focus
News Focus
Post# of 257438
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

caravon

Send PM Follow Ignore
Followers 12
Posts 1058
Boards Moderated 0
Alias Born 02/21/2007

caravon

Re: willyw post# 188209

Thursday, 03/05/2015 10:54:25 PM

Thursday, March 05, 2015 10:54:25 PM

Post# of 257438
willyw,

Did you attend the last Enta's AM?

If you did, you remember that Luly has spent at least 30 minutes explaining the specificity and Enta general drug development philosophy for HCV.

Luly also explained why Gild selected to buy Pharmasset for $11B instead of developing their own HCV candidates at that time.

Regards, caravon
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today